This past week, Scynexis announced the FDA granted both Qualified Infectious Disease Product (QIDP) and Fast Track designations to SCY-247, the company’s second-generation triterpenoid antifungal therapy. These regulatory decisions demonstrate…
Category: 6. Business
-
ctDNA Positivity Associated With Worse Survival, Higher Recurrence Risk in Patients With NSCLC
Circular tumor DNA (ctDNA) positivity is associated with poorer survival and higher recurrence rates among patients with
non–small cell lung cancer (NSCLC), but early detection may allow for timely intervention and improved outcomes, according…Continue Reading
-
BofA Sees Stronger Fee Outlook Supporting BlackRock, Inc. (BLK)’s Longer-Term Earnings Path
BlackRock, Inc. (NYSE:BLK) is included among
Dividend Contenders List: Top 20 Stocks.
BofA Sees Stronger Fee Outlook Supporting BlackRock, Inc. (BLK)’s Longer-Term Earnings Path Source: unsplash
On January 16, BofA raised its…
Continue Reading
-
Sam Altman’s make-or-break year: can the OpenAI CEO cash in his bet on the future? | Sam Altman
OpenAI CEO Sam Altman poses during the Artificial Intelligence (AI) Action Summit, at the Grand Palais, in Paris, on February 11, 2025. Photograph: Joel Saget/AFP via Getty Images Sam Altman has claimed over the years that the advancement of AI…
Continue Reading
-
Frequent Use of AI in the Workplace Continued to Rise in Q4
U.S. employees already using artificial…
Continue Reading
-
Here’s What Analysts Think Will Happen Next
D.R. Horton, Inc. (NYSE:DHI) investors will be delighted, with the company turning in some strong numbers with its latest results. The company beat expectations with revenues of US$6.9b arriving 3.6% ahead of forecasts. Statutory earnings per…
Continue Reading
-
The Targeted Pulse: Clinical Advancements and FDA News | Targeted Oncology
Welcome to this week’s edition of The Targeted Pulse. This week in oncology, we saw a number of significant developments, from FDA approvals to promising clinical trial data for various cancer types. Here is a summary of the top stories.
The FDA…
Continue Reading
-
Israeli cyber sector soars as exits hit $72.6b. in 2025
Israel’s cybersecurity industry closed 2025 with extraordinary momentum, posting record fundraising totals and an unprecedented surge in exit value, according to new data released by Cybertech Global and IVC ahead of the Cybertech Global Tel…
Continue Reading
